CD34 and myelodysplastic syndrome: Myelodysplastic syndrome (MDS) is a collection of hematopoietic malignancies in which genomic abnormalities within the CD34+ hematopoietic stem/progenitor cell (HSPC) compartment lead to ineffective hematopoiesis and morphological dysplasia of blood cells1.